Department of Medicine 5 – Haematology and Oncology

The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML (2025) Stasik S, Eckardt JN, Röllig C, Baldus CD, Platzbecker U, Serve H, Müller-Tidow C, et al. Journal article Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in Parkinson’s disease (2025) Gerasimova E, Beenen A, Kachkin D, Regensburger M, Zundler S, Blumenthal DB, Lutzny-Geier G, et al. Journal article, Original article Expression of vesiculation-related genes is associated with a tumor-promoting microenvironment: a pan-cancer analysis (2025) Westermann L, Diergaarde B, Heidegger S, Poeck H, Szczepański MJ, Reichert TE, Spörl S, et al. Journal article Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience (2025) Innocenti I, Quaranta T, Tomasso A, Mosca A, Benintende G, Fresa A, Larocca LM, et al. Journal article A Practical Guideline for MicroRNA Sequencing Data Analysis in Chronic Lymphocytic Leukemia (2025) Suomela T, Zhang L, Vera J, Bruns H, Lai X Book chapter / Article in edited volumes Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group (2025) Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, Hogan W, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients (2025) Dingfelder J, Taubmann J, von Heydebrand F, Aigner M, Bergmann C, Knitza J, Park S, et al. Journal article Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. (2025) Unglaub JM, Schlenk RF, Middeke JM, Krause S, Kraus S, Einsele H, Kramer M, et al. Journal article Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience (2024) Innocenti I, Mosca A, Tomasso A, Galitzia A, Scarfò L, Morelli F, Galli E, et al. Journal article